Towards developing criteria for scleroderma renal crisis: A scoping review

Autoimmunity Reviews

Volumn 16, Issue 4, 2017, Pages 407-415

  Hoa, Sabrina ^b,c   Stern, Edward P ^d   Denton, Christopher P ^d   Hudson, Marie ^b,c,e   Baron, M ^a   Frech, T ^a   Ghossein, C ^a   Johnson, S ^a   Mouthon, L ^a   Proudman, S ^a   Steen, V ^a   Varga, J ^a  

^a Montreal ^*  (United States)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

Definition; Renal crisis; Scleroderma (or systemic sclerosis); Scoping review

Indexed keywords

ACUTE KIDNEY FAILURE; GOLD STANDARD; HUMAN; HYPERTENSION; HYPERTENSION ENCEPHALOPATHY; KIDNEY BIOPSY; KIDNEY FAILURE; REVIEW; SCLERODERMA; SEIZURE; THROMBOTIC THROMBOCYTOPENIC PURPURA; AUTOIMMUNE DISEASE; COMPLICATION; RENAL INSUFFICIENCY, CHRONIC; SYSTEMIC SCLEROSIS;

AUTOIMMUNE DISEASES; HUMANS; RENAL INSUFFICIENCY, CHRONIC; SCLERODERMA, SYSTEMIC;

EID: 85014499315     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2017.02.012     Document Type: Review

References (45)

1. [1] Desbois, A.C., Cacoub, P., Systemic sclerosis: an update in 2016. Autoimmun Rev 15 (2016), 417–426.
2. [2] Almeida, C., Almeida, I., Vasconcelos, C., Quality of life in systemic sclerosis. Autoimmun Rev 14 (2015), 1087–1096.
3. [3] Murdaca, G., Contatore, M., Gulli, R., Mandich, P., Puppo, F., Genetic factors and systemic sclerosis. Autoimmun Rev 15 (2016), 427–432.
4. [4] Nihtyanova, S.I., Schreiber, B.E., Ong, V.H., Rosenberg, D., Moinzadeh, P., Coghlan, J.G., et al. Prediction of pulmonary complications and long-term survival in systemic sclerosis. Arthritis Rheumatol 66 (2014), 1625–1635.
5. [5] Steen, V.D., Syzd, A., Johnson, J.P., Greenberg, A., Medsger, T.A. Jr., Kidney disease other than renal crisis in patients with diffuse scleroderma. J Rheumatol 32 (2005), 649–655.
6. [6] Caron, M., Hudson, M., Baron, M., Nessim, S., Steele, R., Canadian Scleroderma Research, G., Longitudinal study of renal function in systemic sclerosis. J Rheumatol 39 (2012), 1829–1834.
7. [7] van den Hoogen, F., Khanna, D., Fransen, J., Johnson, S.R., Baron, M., Tyndall, A., et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 72 (2013), 1747–1755.
8. [8] Steen, V.D., Mayes, M.D., Merkel, P.A., Assessment of kidney involvement. Clin Exp Rheumatol 21 (2003), S29–S31.
9. [9] Hudson, M., Baron, M., Tatibouet, S., Furst, D.E., Khanna, D., International Scleroderma Renal Crisis Study I, Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-results from the international scleroderma renal crisis survey. Semin Arthritis Rheum 43 (2014), 666–672.
10. [10] Arksey, H., O'Malley, L., Scoping studies: towards a methodological framework. Int J Soc Res Methodol 8 (2005), 19–32.
11. [11] Pham, M.T., Rajic, A., Greig, J.D., Sargeant, J.M., Papadopoulos, A., McEwen, S.A., A scoping review of scoping reviews: advancing the approach and enhancing the consistency. Res Synth Methods 5 (2014), 371–385.
12. [12] Bramer, W.M., Giustini, D., de Jonge, G.B., Holland, L., Bekhuis, T., De-duplication of database search results for systematic reviews in EndNote. J Med Libr Assoc 104 (2016), 240–243.
13. [13] Nguyen, B., Mayes, M.D., Arnett, F.C., del Junco, D., Reveille, J.D., Gonzalez, E.B., et al. HLA-DRB1 0407 and 1304 are risk factors for scleroderma renal crisis. Arthritis Rheum 63 (2011), 530–534.
14. [14] Traub, Y.M., Shapiro, A.P., Rodnan, G.P., Medsger, T.A., McDonald, R.H. Jr., Steen, V.D., et al. Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of a 25-year experience with 68 cases. Medicine (Baltimore) 62 (1983), 335–352.
15. [15] Hesselstrand, R., Scheja, A., Wuttge, D.M., Scleroderma renal crisis in a Swedish systemic sclerosis cohort: survival, renal outcome, and RNA polymerase III antibodies as a risk factor. Scand J Rheumatol 41 (2012), 39–43.
16. [16] Steen, V.D., Medsger, T.A. Jr., Osial, T.A. Jr., Ziegler, G.L., Shapiro, A.P., Rodnan, G.P., Factors predicting development of renal involvement in progressive systemic sclerosis. Am J Med 76 (1984), 779–786.
17. [17] Avouac, J., Walker, U.A., Hachulla, E., Riemekasten, G., Cuomo, G., Carreira, P.E., et al. Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study. Ann Rheum Dis 75 (2016), 103–109.
18. [18] Montanelli, G., Beretta, L., Santaniello, A., Scorza, R., Effect of dihydropyridine calcium channel blockers and glucocorticoids on the prevention and development of scleroderma renal crisis in an Italian case series. Clin Exp Rheumatol 31 (2013), 135–139.
19. [19] Guillevin, L., Berezne, A., Seror, R., Teixeira, L., Pourrat, J., Mahr, A., et al. Scleroderma renal crisis: a retrospective multicentre study on 91 patients and 427 controls. Rheumatology (Oxford) 51 (2012), 460–467.
20. [20] Penn, H., Howie, A.J., Kingdon, E.J., Bunn, C.C., Stratton, R.J., Black, C.M., et al. Scleroderma renal crisis: patient characteristics and long-term outcomes. QJM 100 (2007), 485–494.
21. [21] Montagna, G.L., Baruffo, A., Maja, L., Tirri, E., Matrone, C., Vatti, M., et al. Scleroderma renal crisis analysis of prevalence and outcome in a large italian series. J Clin Rheumatol 3 (1997), 186–193.
22. [22] DeMarco, P.J., Weisman, M.H., Seibold, J.R., Furst, D.E., Wong, W.K., Hurwitz, E.L., et al. Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial. Arthritis Rheum 46 (2002), 2983–2989.
23. [23] Terras, S., Hartenstein, H., Hoxtermann, S., Gambichler, T., Kreuter, A., RNA polymerase III autoantibodies may indicate renal and more severe skin involvement in systemic sclerosis. Int J Dermatol, 24, 2015.
24. [24] Hamaguchi, Y., Kodera, M., Matsushita, T., Hasegawa, M., Inaba, Y., Usuda, T., et al. Clinical and immunologic predictors of scleroderma renal crisis in Japanese systemic sclerosis patients with anti-RNA polymerase III autoantibodies. Arthritis Rheumatol 67 (2015), 1045–1052.
25. [25] Nikpour, M., Hissaria, P., Byron, J., Sahhar, J., Micallef, M., Paspaliaris, W., et al. Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort. Arthritis Res Ther, 13, 2011, R211.
26. [26] Nguyen, B., Assassi, S., Arnett, F.C., Mayes, M.D., Association of RNA polymerase III antibodies with scleroderma renal crisis. J Rheumatol, 37, 2010, 1068 [author reply 9].
27. [27] Hamaguchi, Y., Kuwana, M., Fujimoto, M., Reply: to PMID 25512203. Arthritis Rheumatol, 67, 2015, 2548.
28. [28] Walker, J.G., Ahern, M.J., Smith, M.D., Coleman, M., Pile, K., Rischmueller, M., et al. Scleroderma renal crisis: poor outcome despite aggressive antihypertensive treatment. Intern Med J 33 (2003), 216–220.
29. [29] Takahashi, T., Asano, Y., Noda, S., Aozasa, N., Akamata, K., Taniguchi, T., et al. A possible contribution of lipocalin-2 to the development of dermal fibrosis, pulmonary vascular involvement and renal dysfunction in systemic sclerosis. Br J Dermatol 173 (2015), 681–689.
30. [30] Yanaba, K., Asano, Y., Tada, Y., Sugaya, M., Kadono, T., Hamaguchi, Y., et al. Increased serum soluble CD147 levels in patients with systemic sclerosis: association with scleroderma renal crisis. Clin Rheumatol 31 (2012), 835–839.
31. [31] Akamata, K., Asano, Y., Noda, S., Taniguchi, T., Takahashi, T., Ichimura, Y., et al. An inverse correlation of serum angiogenin levels with estimated glomerular filtration rate in systemic sclerosis patients with renal dysfunction. Eur J Dermatol 23 (2013), 269–270.
32. [32] Vancheeswaran, R., Magoulas, T., Efrat, G., Wheeler-Jones, C., Olsen, I., Penny, R., et al. Circulating endothelin-1 levels in systemic sclerosis subsets–a marker of fibrosis or vascular dysfunction?. J Rheumatol 21 (1994), 1838–1844.
33. [33] Teixeira, L., Mouthon, L., Mahr, A., Berezne, A., Agard, C., Mehrenberger, M., et al. Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients. Ann Rheum Dis 67 (2008), 110–116.
34. [34] Steen, V.D., Medsger, T.A. Jr., Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Arthritis Rheum 41 (1998), 1613–1619.
35. [35] Arad, U., Balbir-Gurman, A., Doenyas-Barak, K., Amit-Vazina, M., Caspi, D., Elkayam, O., Anti-neutrophil antibody associated vasculitis in systemic sclerosis. Semin Arthritis Rheum 41 (2011), 223–229.
36. [36] Chan, P.T., Mok, C.C., Pauci-immune crescentic glomerulonephritis in limited cutaneous systemic sclerosis. Clin Rheumatol 31 (2012), 1273–1277.
37. [37] Endo, H., Hosono, T., Kondo, H., Antineutrophil cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis. J Rheumatol 21 (1994), 864–870.
38. [38] Iwagami, M., Kubo, K., Tanaka, R., Kawahata, K., Okamoto, A., Hagino, N., et al. Thrombotic thrombocytopenic purpura with severe hypertension in a patient with systemic sclerosis sine scleroderma and polymyositis. Intern Med 50 (2011), 2413–2416.
39. [39] Manadan, A.M., Harris, C., Block, J.A., Thrombotic thrombocytopenic purpura in the setting of systemic sclerosis. Semin Arthritis Rheum 34 (2005), 683–688.
40. [40] Yusin, J., Lewin, K., Clements, P., Thrombotic thrombocytopenia purpura in a patient with systemic sclerosis. J Clin Rheumatol 7 (2001), 106–111.
41. [41] Badwal, S., Kotwal, J., Varma, P.P., Unusual case of pulmonary renal syndrome with autopsy findings. Indian J Pathol Microbiol 56 (2013), 294–296.
42. [42] Ligon, C.B., Hummers, L.K., McMahan, Z.H., Oxalate nephropathy in systemic sclerosis: case series and review of the literature. Semin Arthritis Rheum 45 (2015), 315–320.
43. [43] Mascio, H.M., Joya, C.A., Plasse, R.A., Baker, T.P., Flessner, M.F., Nee, R., An unusual cause of acute kidney injury due to oxalate nephropathy in systemic scleroderma. Clin Nephrol 84 (2015), 111–115.
44. [44] Mpofu, S., Rhodes, J.M., Mpofu, C.M., Moots, R.J., An unusual cause of acute renal failure in systemic sclerosis. Ann Rheum Dis 62 (2003), 1133–1134.
45. [45] Shinohara, M., Washida, N., Tanaka, A., Ueda, S., Kuwahara, T., Kojima, H., ACE inhibitor-induced acute renal failure in a patient with progressive systemic sclerosis: ischemic nephropathy mimicking PSS renal crisis. Intern Med 46 (2007), 1605–1607.